Teva Launches Generic Pravachol Following Appeals Court Dismissal Of Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson concurrently launched an authorized generic of Bristol's pravastatin, but Ranbaxy's 80 mg ANDA remains on hold.